Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Verena Kraehling"'
Autor:
Sandro Halwe, René Gottschalk, Verena Kraehling, Cornelius Rohde, Michael Schmidt, Helena Mueller, Jochen Wilhelm, Stephan Becker, Massimiliano Savini, Martin Kern, Sandra Ciesek
So far, 170,000 Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infections have been confirmed in Germany, of which more than 5,000 have been detected in the Frankfurt am Main metropolitan region. When examining 1,000 nasopharyng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ad18e7b3b05527457b1ac5e2a775b6
Autor:
Jake E McGreig, Jindrich Cinatl, Mark N. Wass, Katie-May McLaughlin, Denisa Bojkova, Marek Widera, Martin Michaelis, Sandra Ciesek, Verena Kraehling, Stuart G Masterson
SARS-CoV-2 is a novel coronavirus currently causing a pandemic. We show that the majority of amino acid positions, which differ between SARS-CoV-2 and the closely related SARS-CoV, are differentially conserved suggesting differences in biological beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3068baa2e84f432d6db2c4d34e57446
Autor:
Alexandra Kupke, Cornelius Rohde, Michelle Gellhorn-Serra, Lucie Sauerhering, Nico Becker, Anke Werner, Henning Gruell, Florian Klein, Falk Liberta, Markus Eickmann, Joerg C. Schmidt, Marek Widera, Stephan Becker, Zheng Cai, Sandra Ciesek, Guangwei Yang, Lennart Kaemper, Sandro Halwe, Felix Schiele, Michael Kluever, Manuel Koch, David Young, Verena Kraehling, Christoph Kreer, Matthias Zehner, Kanika Vanshylla, Fei Han, Michael S Marlow
Publikováno v:
Viruses
Volume 13
Issue 8
Viruses, Vol 13, Iss 1498, p 1498 (2021)
Volume 13
Issue 8
Viruses, Vol 13, Iss 1498, p 1498 (2021)
Despite recent availability of vaccines against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), there is an urgent need for specific anti-SARS-CoV-2 drugs. Monoclonal neutralizing antibodies are an important drug class in the globa
Autor:
Sabine Yerly, Saskia Borregaard, Benjamin Tsofa, Axel Finckh, Marylyn M. Addo, Laurent Kaiser, Christophe Combescure, Sarah Katharina Fehling, Martin P. Grobusch, Alen Jambrecina, Philip Bejon, Marie-Paule Kieny, Markus Eickmann, Selidji T Agnandji, Nadine Biedenkopf, Michael Ramharter, Patricia Njuguna, Alain Matthey, Domtila Kimani, Rahel Kasonta, Ansgar W. Lohse, Angela Huttner, Emmanuel B. Bache, Patricia E. Fast, Hans Stubbe, Rebekah Burrow, Vasee S. Moorthy, Verena Kraehling, Henry M. Staines, Stefan Schmiedel, Anne Nolting, Gürkan Kaya, A.A. Adegnika, Jessica S Brosnahan, Jay W. Hooper, Marguerite Massinga-Loembe, Thomas Strecker, Sanjeev Krishna, Stephan Becker, Christine Dahlke, José Francisco Fernandes, Sherif R. Zaki, Caroline Ogwang, Floriane Auderset, Benjamin Mordmüller, Peter Silvera, Madeleine E Zinser, Claire-Anne Siegrist, Ana Rita Gonçalves, Jules Alexandre Desmeules, Anita Lumeka Kabwende, Jonas Schmidt-Chanasit, Julie-Anne Dayer, Peter G. Kremsner, Bertrand Lell, Barbara Lemaître, Felix R. Stahl, Marcus Altfeld
Publikováno v:
New England journal of medicine, 374(17), 1647-1660. Massachussetts Medical Society
BACKGROUND: The replication-competent recombinant vesicular stomatitis virus (rVSV)-based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa. METHODS: We p
Autor:
Stephan Becker, Tanmay A.M. Bharat, Takeshi Noda, Verena Kraehling, Yoshihiro Kawaoka, Larissa Kolesnikova, James D. Riches, John A. G. Briggs
Publikováno v:
Proceedings of the National Academy of Sciences
Ebola virus is a highly pathogenic filovirus causing severe hemorrhagic fever with high mortality rates. It assembles heterogenous, filamentous, enveloped virus particles containing a negative-sense, single-stranded RNA genome packaged within a helic